United States · FDA National Drug Code directory
Atovaquone and Proguanil Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68462-404_a6232b89-d1c0-4114-879d-6c9320a92eb2
- Product NDC
- 68462-404
- Form
- TABLET, FILM COATED
- Composition / generic term
- Atovaquone and Proguanil Hydrochloride
- Labeler
- Glenmark Pharmaceuticals Inc.,USA
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20110915
- Source listing expiry
- 20271231
Source-listed ingredients
- ATOVAQUONE — 250 mg/1
- PROGUANIL HYDROCHLORIDE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (68462-404-01) · 68462-404-01
- 2 BLISTER PACK in 1 CARTON (68462-404-67) / 12 TABLET, FILM COATED in 1 BLISTER PACK (68462-404-44) · 68462-404-67
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →